|
1
|
Delaney G, Jacob S, Featherstone C and
Barton M: The role of radiotherapy in cancer treatment: estimating
optimal utilization from a review of evidence-based clinical
guidelines. Cancer. 104:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rzeszowska-Wolny J, Przybyszewski WM and
Widel M: Ionizing radiation-induced bystander effects, potential
targets for modulation of radiotherapy. Eur J Pharmacol.
625:156–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Runkle EA, Zhang H, Cai Z, et al:
Reversion of the ErbB malignant phenotype and the DNA damage
response. Exp Mol Pathol. 93:324–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yin E, Nelson DO, Coleman MA, Peterson LE
and Wyrobek AJ: Gene expression changes in mouse brain after
exposure to low-dose ionizing radiation. Int J Radiat Biol.
79:759–775. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Correa CR and Cheung VG: Genetic variation
in radiation-induced expression phenotypes. Am J Hum Genet.
75:885–890. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai MH, Cook JA, Chandramouli GV, et al:
Gene expression profiling of breast, prostate, and glioma cells
following single versus fractionated doses of radiation. Cancer
Res. 67:3845–3852. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
John-Aryankalayil M, Palayoor ST, Cerna D,
et al: Fractionated radiation therapy can induce a molecular
profile for therapeutic targeting. Radiat Res. 174:446–458. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
10
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo X, Wu Y and Hartley RS: MicroRNA-125a
represses cell growth by targeting HuR in breast cancer. RNA Biol.
6:575–583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Yuan C, Lv K, et al: Lin28
mediates radiation resistance of breast cancer cells via regulation
of caspase, H2A.X and Let-7 signaling. PLoS One. 8:e673732013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KM, Choi EJ and Kim IA: microRNA-7
increases radiosensitivity of human cancer cells with activated
EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin J, Liu C, Gao F, et al: miR-200c
enhances radiosensitivity of human breast cancer cells. J Cell
Biochem. 114:606–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Anastasov N, Höfig I, Vasconcellos IG, et
al: Radiation resistance due to high expression of miR-21 and G2/M
checkpoint arrest in breast cancer cells. Radiat Oncol. 7:2062012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi H, Liang B, Jia J, et al: Differential
roles of miR-199a-5p in radiation-induced autophagy in breast
cancer cells. FEBS Lett. 587:436–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Körner C, Keklikoglou I, Bender C, Wörner
A, Münstermann E and Wiemann S: MicroRNA-31 sensitizes human breast
cells to apoptosis by direct targeting of protein kinase C ɛ
(PKCɛ). J Biol Chem. 288:8750–8761. 2013.PubMed/NCBI
|
|
19
|
Cloonan N, Wani S, Xu Q, et al: MicroRNAs
and their isomiRs function cooperatively to target common
biological pathways. Genome Biol. 12:R1262011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
John-Aryankalayil M, Palayoor ST, Makinde
AY, et al: Fractionated radiation alters oncomir and tumor
suppressor miRNAs in human prostate cancer cells. Radiat Res.
178:105–117. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ebhardt HA, Tsang HH, Dai DC, Liu Y,
Bostan B and Fahlman RP: Meta-analysis of small RNA-sequencing
errors reveals ubiquitous post-transcriptional RNA modifications.
Nucleic Acids Res. 37:2461–2470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Landgraf P, Rusu M, Sheridan R, et al: A
mammalian microRNA expression atlas based on small RNA library
sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reid JG, Nagaraja AK, Lynn FC, et al:
Mouse let-7 miRNA populations exhibit RNA editing that is
constrained in the 5′-seed/ cleavage/anchor regions and stabilize
predicted mmu-let-7a:mRNA duplexes. Genome Res. 18:1571–1581.
2008.PubMed/NCBI
|
|
24
|
Morin RD, O’Connor MD, Griffith M, et al:
Application of massively parallel sequencing to microRNA profiling
and discovery in human embryonic stem cells. Genome Res.
18:610–621. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Li X, Miao Y, et al:
SubpathwayMiner: a software package for flexible identification of
pathways. Nucleic Acids Res. 37:e1312009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayashita Y, Osada H, Tatematsu Y, et al:
A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005.PubMed/NCBI
|
|
29
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pan HW, Li SC and Tsai KW: MicroRNA
dysregulation in gastric cancer. Curr Pharm Des. 19:1273–1284.
2013.PubMed/NCBI
|
|
31
|
Zhao L, Bode AM, Cao Y and Dong Z:
Regulatory mechanisms and clinical perspectives of miRNA in tumor
radiosensitivity. Carcinogenesis. 33:2220–2227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang HT, Li SC, Ho MR, et al:
Comprehensive analysis of microRNAs in breast cancer. BMC Genomics.
13(Suppl 7): S182012.PubMed/NCBI
|
|
33
|
Ferracin M, Querzoli P, Calin GA and
Negrini M: MicroRNAs: toward the clinic for breast cancer patients.
Semin Oncol. 38:764–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ng EK, Wong CL, Ma ES and Kwong A:
MicroRNAs as new players for diagnosis, prognosis, and therapeutic
targets in breast cancer. J Oncol. 2009:3054202009.PubMed/NCBI
|
|
35
|
Iorio MV, Casalini P, Piovan C, Braccioli
L and Tagliabue E: Breast cancer and microRNAs: therapeutic impact.
Breast. 20(Suppl 3): S63–S70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Camps C, Buffa FM, Colella S, et al:
hsa-miR-210 is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kovalchuk O, Filkowski J, Meservy J, et
al: Involvement of microRNA-451 in resistance of the MCF-7 breast
cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther.
7:2152–2159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Si H, Sun X, Chen Y, et al: Circulating
microRNA-92a and microRNA-21 as novel minimally invasive biomarkers
for primary breast cancer. J Cancer Res Clin Oncol. 139:223–229.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao L, Lu X and Cao Y: MicroRNA and
signal transduction pathways in tumor radiation response. Cell
Signal. 25:1625–1634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Weidhaas JB, Babar I, Nallur SM, et al:
MicroRNAs as potential agents to alter resistance to cytotoxic
anticancer therapy. Cancer Res. 67:11111–11116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang Z, Ahn J, Guo D, Votaw JR and Shim
H: MicroRNA-302 replacement therapy sensitizes breast cancer cells
to ionizing radiation. Pharm Res. 30:1008–1016. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de Rinaldis E, Gazinska P, Mera A, et al:
Integrated genomic analysis of triple-negative breast cancers
reveals novel microRNAs associated with clinical and molecular
phenotypes and sheds light on the pathways they control. BMC
Genomics. 14:6432013.
|
|
44
|
Kim K, Chadalapaka G, Lee SO, et al:
Identification of oncogenic microRNA-17-92/ZBTB4/specificity
protein axis in breast cancer. Oncogene. 31:1034–1044. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Bian C, Liao L, Li J and Zhao RC:
miR-17-5p promotes human breast cancer cell migration and invasion
through suppression of HBP1. Breast Cancer Res Treat. 126:565–575.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jiang P, Rao EY, Meng N, Zhao Y and Wang
JJ: MicroRNA-17-92 significantly enhances radioresistance in human
mantle cell lymphoma cells. Radiat Oncol. 5:1002010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kuerbitz SJ, Plunkett BS, Walsh WV and
Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant
following irradiation. Proc Natl Acad Sci USA. 89:7491–7495. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Simone CB II, John-Aryankalayil M,
Palayoor ST, et al: mRNA expression profiles for prostate cancer
following fractionated irradiation are influenced by p53 status.
Transl Oncol. 6:573–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yan HL, Xue G, Mei Q, et al: Repression of
the miR-17-92 cluster by p53 has an important function in
hypoxia-induced apoptosis. EMBO J. 28:2719–2732. 2009.
|
|
50
|
Thomas M, Lange-Grunweller K, Hartmann D,
et al: Analysis of transcriptional regulation of the human
miR-17-92 cluster; evidence for involvement of Pim-1. Int J Mol
Sci. 14:12273–12296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li Y, Li Y, Zhang H and Chen Y:
MicroRNA-mediated positive feedback loop and optimized bistable
switch in a cancer network involving miR-17-92. PLoS One.
6:e263022011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Aguda BD, Kim Y, Piper-Hunter MG, Friedman
A and Marsh CB: MicroRNA regulation of a cancer network:
consequences of the feedback loops involving miR-17-92, E2F, and
Myc. Proc Natl Acad Sci USA. 105:19678–19683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Papanikolaou V, Iliopoulos D, Dimou I, et
al: Survivin regulation by HER2 through NF-κB and c-myc in
irradiated breast cancer cells. J Cell Mol Med. 15:1542–1550.
2011.
|
|
54
|
Orr MS, Watson NC, Sundaram S, Randolph
JK, Jain PT and Gewirtz DA: Ionizing radiation and teniposide
increase p21waf1/cip1 and promote Rb dephosphorylation
but fail to suppress E2F activity in MCF-7 breast tumor cells. Mol
Pharmacol. 52:373–379. 1997.PubMed/NCBI
|
|
55
|
Calaf GM and Hei TK: Ionizing radiation
induces alterations in cellular proliferation and c-myc, c-jun and
c-fos protein expression in breast epithelial cells. Int J Oncol.
25:1859–1866. 2004.PubMed/NCBI
|
|
56
|
Wang Y, Huang JW, Li M, et al:
MicroRNA-138 modulates DNA damage response by repressing histone
H2AX expression. Mol Cancer Res. 9:1100–1111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Niemoeller OM, Niyazi M, Corradini S, et
al: MicroRNA expression profiles in human cancer cells after
ionizing radiation. Radiat Oncol. 6:292011. View Article : Google Scholar : PubMed/NCBI
|
